Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.
Navarese EP, Podhajski P, Andreotti F, La Torre G, Gajda R, Radziwanowski A, Nowicka M, Bukowski P, Gajda J, Omyła M, Lackowski P, Piasecki M, Jasiewicz M, Szymański P, Pietrzykowski Ł, Michalski P, Kubica A, Urbanowicz I, Orsini N, Conte M, Pinkas J, Brouwer MA, Kubica J.
Navarese EP, et al. Among authors: gajda j.
Cardiol J. 2022;29(5):739-750. doi: 10.5603/CJ.a2022.0072. Epub 2022 Aug 1.
Cardiol J. 2022.
PMID: 35912711
Free PMC article.
Clinical Trial.